Molecular Iodine Formulation Killed Pathogens Rapidly
A UC San Diego study showed new topical iodine solutions eliminated over 99.9% of tested pathogens within 15 seconds.
Updated on Oct. 12, 2026 in Life Sciences
Live Poll
Do you trust that new antimicrobial technologies significantly improve hospital safety in your area?
Researchers at the University of California San Diego confirmed that new molecular iodine formulations from I2Pure effectively neutralised 17 distinct bacterial and fungal pathogens. The study verified that these topical liquids and gels achieve a 99.9% reduction in colony-forming units in just 15 seconds.
Why it matters
This research evaluates a potential alternative to traditional antiseptics that combines rapid antimicrobial action with lower residual staining. Demonstrating prolonged surface activity suggests these formulations could provide sustained protection against dangerous clinical pathogens.
The study tested three formulations against 17 pathogens, including MRSA and Candida auris, and confirmed antimicrobial activity remained present 24 hours after surface application. Researchers quantified performance by measuring log10 reductions in colony-forming units.
The players
I2Pure
This company develops proprietary molecular iodine technologies and antimicrobial formulations for clinical and commercial use.
University of California San Diego
This public research university conducts extensive medical and scientific studies through its various health sciences and engineering departments.
The details
The study, published in the journal Antimicrobial Agents and Chemotherapy, tested three distinct topical forms including liquids and a gel. These I2Pure products demonstrated effectiveness against a range of drug-resistant organisms such as VRE and Klebsiella pneumoniae while leaving minimal stains compared to standard alternatives.
Timeline
October 12, 2026: I2Pure announced the formal publication of the study results.
The Big Picture
This research advances the clinical evaluation of iodine-based antiseptic alternatives by providing specific performance metrics for novel molecular formulations. It bridges the gap between traditional broad-spectrum agents and high-efficacy, low-stain topical treatments.
These findings could eventually lead to more effective topical treatments for infection control in medical facilities and potentially consumer settings. The reduction in staining and fast-acting profile may improve patient comfort and compliance with antiseptic protocols.
The takeaway
The rapid kill rate observed in this study highlights the efficacy of molecular iodine in modern clinical environments. Practitioners and consumers should monitor for future product releases that incorporate these specialized formulations into everyday hygiene practices.
Further reading
For more background on current advancements in medical research, visit the Life Sciences section.
More information
Review the full details regarding this research on the I2Pure researcher profile information.
Source note: This article includes information reported by VentureBeat.
Live Poll
Do you trust that new antimicrobial technologies significantly improve hospital safety in your area?
